EQRxNews Page EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…Arboretum_JDMarch 23, 2022
EQRxNews Page EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 18, 2022
EQRxNews Page EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 10, 2022
EQRxHome PageNews Page EQRx Debuts as Publicly Traded Company CM Life Sciences III (Nasdaq: CMLT, CMLTW, CMLTU), a life science-focused special purpose acquisition company,…Arboretum_JDDecember 17, 2021
EQRxNews Page EQRx and CM Life Sciences III Announce Stockholder Meeting Details to Vote on Proposed Business Combination EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…Arboretum_JDDecember 2, 2021
EQRxNews Page Partnership Announcements for EQRx – Commercialization with Abdul Latif Jameel Health and Drug Discovery & Development with Evotech EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in…Arboretum_JDNovember 22, 2021
EQRxNews Page EQRx and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…Arboretum_JDOctober 20, 2021
EQRxNews Page Turning Point Therapeutics and EQRx Announce Clinical Collaboration Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib…Arboretum_JDOctober 14, 2021
EQRxNews Page EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…Arboretum_JDOctober 7, 2021
EQRxHome PageNews Page EQRx to Accelerate Growth with $1.8B Raise through Proposed Combination with CM Life Sciences III EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new…Arboretum_JDAugust 6, 2021